R

Red Maple Trials | Clinical Team

Research site

(Unclaimed)

Location

2935 Conroy Rd Unit 110, Ottawa, Ontario, Canada

Site insights

Top conditions

Top treatments

EVO756

REGN1908-1909

RPT193

BLU-808

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).

Enrolling

Chronic Spontaneous Urticaria

Drug: EVO756

Drug: Placebo control

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

VBI-2901a is an investigational vaccine candidate that uses enveloped virus-like particles (eVLPs) to express the spike proteins of three coronavirus...

Active, not recruiting

COVID-19

Coronavirus Infections

Biological: VBI-2901a

Study of DM-101PX in Adults With Birch Pollen Allergy (BASIT)

Randomized, double-blind placebo-controlled phase 2 trial with the aim to investigate safety and efficacy of DM-101-PX in reducing allergic symptoms...

Active, not recruiting

Birch Pollen Allergy

Biological: Placebo

Biological: DM-101PX